Company: AGIO
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0001439222-25-000009
Chunk: 803

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-02-13
Form: 10-K
Item: Item 8
Chunk 803
---
ement Restricted Stock Unit Agreement for Brian Goff10-Q001-36014August 4, 202210.4

87

10.24#**Form of Inducement Performance Stock Unit Agreement for Brian Goff10-Q001-36014August 4, 202210.510.25#Letter Agreement, dated as of September 16, 2022, between the Registrant and Cecilia Jones10-Q001-36014November 3, 202210.510.26#Form of Inducement Stock Option Agreement for Cecilia JonesS-8333- 267624September 26, 202299.110.27#Form of Inducement Restricted Stock Unit Agreement for Cecilia JonesS-8333- 267624September 26, 202299.210.28#**Form of Inducement Performance Stock Unit Agreement for Cecilia JonesS-8333- 267624September 26, 202299.310.29#Amended and Restated Severance Benefits Plan8-K001-36014October 7, 202210.110.30#Letter Agreement, dated as of December 5, 2022, between the Registrant and Tsveta Milanova10-K001-36014February 23, 202310.3810.31#Form of Inducement Stock Option Agreement for Tsveta MilanovaS-8333- 269018January 3, 202399.110.32#Form of Inducement Restricted Stock Unit Agreement for Tsveta MilanovaS-8333- 269108January 3, 202399.210.33#**Form of Inducement Performance Stock Unit Agreement for Tsveta MilanovaS-8333- 269108January 3, 202399.310.34#2023 Stock Incentive PlanS-8333-272615June 13, 202399.110.35#Form of Stock Option Agreement Under 2023 Stock Incentive Plan10-Q001-36014August 3, 202310.210.36#Form of Restricted Stock Unit  Agreement Under 2023 Stock Incentive Plan10-Q001-36014August 3, 202310.310.37#Form of Restricted Stock Unit  Agreement (Performance-Based) Under 2023 Stock Incentive Plan10-Q001-36014August 3, 202310.410.38**Purchase and Sale Agreement,